Description
BAY-1082439 is an inhibitor of PI3K. It is selective for the PI3Kα/β/δ isoforms. In vivo, BAY-1082439 has shown efficacy in inhibiting PTEN-null prostate cancer growth.
Product Unit Size | Cost | Quantity | Stock |
---|
BAY-1082439 is an inhibitor of PI3K. It is selective for the PI3Kα/β/δ isoforms. In vivo, BAY-1082439 has shown efficacy in inhibiting PTEN-null prostate cancer growth.
Cas No. | 1375469-38-7 |
---|---|
Purity | ≥98% |
Formula | C25H30N6O5 |
Formula Wt. | 494.55 |
IUPAC Name | N-{8-[(2R)-2-Hydroxy-3-(4-morpholinyl)propoxy]-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl}-2-methylnicotinamide |
Synonym | BAY 1082439, BAY1082439, BAY10-82439, BAY 10-82439, BAY-10-82439 |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Zou Y., Qi Z., et al. Cotargeting the Cell-Intrinsic and Microenvironment Pathways of Prostate Cancer by PI3Kα/β/δ Inhibitor BAY1082439. Mol Cancer Ther. 17(10):2091-99 (2018). PMID: 30045927.
Oxidized non-cylic hexose sugar.
c-Met inhibitor.
Saponin found in Bupleurum, Heteromorpha, and S...
Naturally occurring amino acid found in grains,...
All-trans nonaprenol isoprenoid, found in Solan...
NSAID; COX-1/2 inhibitor.
Butyrophenone; α-adrenergic, D2, histamine ant...
Peptide, neutral ionophore.
Inhibitor of CDK.
Dihydropyridine; L-type and T-type Ca2+ channel...
AT1 inhibitor.
Non-depolarizing NMJ blocker; nAChR antagonist....
Arylbenzimidazole; CHK2 inhibitor.
Macrolide; F1F0 ATP synthase inhibitor.
Macrolide; protein synthesis inhibitor.
Histamine H1 antagonist.
Sulfonylurea; SUR1 antagonist.
Pim kinase inhibitor.
Third generation macrocyclic ALK inhibitor.
Retinoid, differentiation inducer.